371 related articles for article (PubMed ID: 32339782)
1. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy.
Wang E; Wang L; Ding R; Zhai M; Ge R; Zhou P; Wang T; Fang H; Wang J; Huang J
Pharmacol Res; 2020 Jul; 157():104831. PubMed ID: 32339782
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
Zhang Y; Tao C; Xuan C; Jiang J; Cao W
Oxid Med Cell Longev; 2020; 2020():9542165. PubMed ID: 32855769
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
4. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
Dong Y; Zhao Q; Wang Y
Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
[TBL] [Abstract][Full Text] [Related]
6. The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis.
Wu X; Li H; Wan Z; Wang R; Liu J; Liu Q; Zhao H; Wang Z; Zhang H; Guo H; Qi C; Jiao X; Li X
Biomed Pharmacother; 2021 Dec; 144():112267. PubMed ID: 34624679
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
8. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
Gao Y; Su X; Xue T; Zhang N
Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
[TBL] [Abstract][Full Text] [Related]
11. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
[TBL] [Abstract][Full Text] [Related]
14. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis.
Fan Y; Fan H; Li P; Liu Q; Huang L; Zhou Y
Bioengineered; 2022 May; 13(5):11517-11529. PubMed ID: 35510516
[TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
17. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
18. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway.
Lu C; Fan G; Wang D
Int Immunopharmacol; 2020 Jul; 84():106467. PubMed ID: 32344355
[TBL] [Abstract][Full Text] [Related]
19. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
Guo MF; Dai YJ; Gao JR; Chen PJ
J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
